Category Archives: Platelet Rich Plasma Injections

Joint Pain Injections Market Research : Key Companies Profile with Sales, Revenue, Price and Competitive Situation Analysis | Allergan Plc., Pfizer…

Market Synopsis:A New exploration report titled Global Joint Pain Injections market effectively displays the total situation of the global and an individual investigation of the different regional segments. It gives, any place pertinent and important, specialized information of products, and reveals helpful insight into expected business creation dates and current R&D status. This report will help the viewer in Better Decision Making.

For Better Understanding, Download Free Sample PDF Brochure of Joint Pain Injections Market Research Report @https://marketresearch.biz/report/joint-pain-injections-market/request-sample

MarketResearch.Biz offers 2019report on Global Joint Pain Injections Market that assesses industry development drifts through chronicled information and appraisals future possibilities dependent on exhaustive research. The report widely gives the piece of the overall industry, development, patterns, and figures for the period 2019-2028.Joint Pain Injections Market investigate report completely clarifies every single viewpoint identified with the Joint Pain Injections Market, which encourages the reports reader to think about and assess the up-coming business sector drift and execute the logical data to advance the business.The development pattern anticipated because of intensive assessment offers inside and out data in regards to the Joint Pain Injections Market. A pathway of improvement is offered by the market to the few associated systems of organizations under it, which incorporate various firms, enterprises, associations, sellers, wholesalers, and nearby producers as well. All the key Joint Pain Injections Market players contend with one another by offering better products and administrations at a sensible cost so as to snatch huge share at the regional and global level market.

The report also provides a competitor analysis of Key Trends & advanced technologies. The Joint Pain Injections (Thousands Units) and Revenue (Million USD) Market Split by Key players such as Allergan Plc., Pfizer Inc, Sanofi, Anika Therapeutics Inc, Ferring B.V., Bioventus LLC, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Seikagaku Corporation, Chugai Pharmaceutical Co Ltd

Joint Pain Injections Market Report segments Cover:

Segmentation by Injection type:

Corticosteroid InjectionsHyaluronic Acid InjectionsOthers (include, Platelet-rich plasma (PRP), Placental tissue matrix (PTM), etc.)Segmentation by joint type:

Knee & AnkleHip JointShoulder & ElbowFacet Joints of the SpineOthers (include, Ball and socket, etc.)Segmentation by end-user:

Hospital PharmaciesRetail PharmaciesOnline Pharmacies

Inquire/Speak To Expert for Further Detailed Information About Joint Pain Injections Report:https://marketresearch.biz/report/joint-pain-injections-market/#inquiry

Joint Pain Injections Market Impressive Report Offerings:

1.It gives a development considering the point of view on various components driving or limiting Joint Pain Injections Market development

2.It helps in tolerating the significant item fragments and their future

3.It conveys stick point investigation of fluctuating challenge elements and keeps you in front of Joint Pain Injections Market contenders

4.It helps in settling on perceptive expert choices by having intensive bits of knowledge of the market and by making inside and out an investigation of market fragments

5.It helps in local promoting type investigation, global exchange type examination, and inventory network investigation;

6. It comprehends Joint Pain Injections fabricating cost structure, crude material, and providers, producing process, industry chain structure;

7.It serves to standpoint limit examination (organization portion), deals investigation (organization fragment), and deals value examination

8.It gives a verifiable conjecture surveyed based on how the Joint Pain Injections Market is anticipated to develop

Share Your Questions Here For More Details On this Report or Customizations As Per Your Need:https://marketresearch.biz/report/joint-pain-injections-market/#request-for-customization

Get in touch with Us:

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue, Suite 300 New York City, NY 10170,

United States

Tel:+ 1-347-826-1876

Website:https://marketresearch.biz/

Continue reading here:
Joint Pain Injections Market Research : Key Companies Profile with Sales, Revenue, Price and Competitive Situation Analysis | Allergan Plc., Pfizer...

A sound theoretical mechanism and clinical indication are not enoughthe case of Platelet Rich Plasma for Achilles tendon ruptures – The BMJ – The BMJ

A global industry has grown around using platelet rich plasma (PRP) in sports medicine. Its appeal has been heightened by use in high profile athletes. PRP has evolved over millennia. As natures most refined healing elixir of minute vessels packed with bioactive proteins, it stood every chance of being that new accelerant of tissue healing.

To produce PRP, the patients own blood is processed, usually in a specialised centrifuge, to produce a solution containing a supraphysiological concentration of platelets. But where does it lie in the spectrum between another fashionable application and a proven novel regenerative therapy? We set out to sift the evidence from the enthusiasm with an open mind, and to place some robust research quality markers that would allow proper critique.

Our 2016 paper in The BMJ discussed the uncertainties in this area, and looked at how effective platelet rich plasma injections are in treating musculoskeletal soft tissue injuries. At the time there had been 29 randomised controlled trials, but it was difficult to draw clear conclusions about efficacy, because of PRP use in heterogeneous musculoskeletal conditions, underpowered studies, and poor reporting. [1]

Furthermore, few trials included an analysis of PRP content or quality, yet PRP had been adopted widely in clinical practice. Many commercially available PRP preparation devices had US Food and Drug Administration approval based on device performance and safety, but not clinical efficacy. [2] However, animal and cellular research was providing some encouraging evidence in support of a theoretical mechanism and potential effect. [3]

It was because of the latter that we embarked upon the PATH-2 trial to investigate the efficacy of PRP. We identified acute Achilles tendon rupture as a suitable human injury to study, as it is common and patients often experience a frustrating recovery, due to slow tissue healing and recovery of muscle function. The case for robust evaluation was clear, however the complexity and cost of a randomised controlled trial were significant. We first conducted a pilot with embedded mechanistic studies to address the limitations of previous trials, then recruited to the largest trial of PRP to date in 19 UK hospitals. To standardise PRP, we provided the same specialist centrifuge to each hospital, standard operating procedures and training in blood sample handling, and tested all blood and PRP samples at a central laboratory. Recruiting participants in busy trauma clinics, and handling the masking of the PRP or dry needle injection were some of the challenges. For our findings to be unequivocal the primary outcome needed to be an instrumented muscle performance test by a blinded assessor; that ensured objective alongside patient-reported outcomes.

The results of the PATH-2 trial are now published in The BMJ, and show that when subjected to robust evaluation, there is no evidence of patient benefit from injecting high quality PRP for acute Achilles tendon ruptures.

It took years of development, trialling, and evaluation, to deliver this negative finding. Some may think that this was a misplaced effort and resources. But safety and efficacy are paramount as no intervention is without risk or cost, even if autologous. This may not be the end of the PRP story. We assumed natures recipe of bioactive proteins released from activated platelets was the ideal, but perhaps some ingredients have more potency than others. There is a clear sense, however, that the many other current musculoskeletal PRP applications now need to be subjected to similar evaluation. There is also a wider message about adopting innovations into practice and the balance with robust clinical trial evaluation. Enthusiasm for using promising technologies and a strong theoretical justification from pre-clinical research are insufficient. This is especially important where new interventions are not subjected to the same regulations as new medicines.

David J Keene, NIHR Postdoctoral Research Fellow, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. @davidkeenePT

Keith Willett, Professor of Orthopaedic Trauma Surgery, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Competing interests: See research paper.

References:

View post:
A sound theoretical mechanism and clinical indication are not enoughthe case of Platelet Rich Plasma for Achilles tendon ruptures - The BMJ - The BMJ

Father-Son Team Creates Beauty and Healing – Atlanta Jewish Times

Every father should remember that one day his son will follow his example instead of his advice. Charles F. Kettering, engineer-inventor

Walking in a fathers shadow ranges from being a challenge to being a prince. The latter is the case of Dr. Farzad Nahai, who relished the path of dad Dr. Foad Nahai, a well-respected professor and practitioner. Learn how their paths unfolded, one working with Navajo Indians and landing as the sole plastic surgeon in a dermatology group, the other a sought after worldwide plastic surgeon, author and speaker who has wielded a scalpel for 44 years.

All-American son Farzad Nahai graduated from the Westminster Schools. Math and science came easily to him, which put him on the path to medical school. He recalled, Dad was my hero. Back then, there were no computers, so at home I looked at his medical slides and over his shoulder in the operating room. Good thing was that I was not bothered by blood! During the summers, I was a scrub tech. He eventually sought out plastic surgery as an opportunity to be thoughtful, creative and solution-oriented.

Get The AJT Newsletter by email and never miss our top storiesFree Sign Up

Father and son practiced together for eight years, before the junior Nahai joined another specialty practice, MetroDerm, P.C., as the only plastic surgeon among 10 dermatologists.

Dr. Farzad Nahai enjoys following in his fathers footsteps.

About 70 percent of his practice is elective versus procedures such as skin cancer reconstruction. I practice the full spectrum of plastic surgery: faces, breasts, full bodies, and injectables. I also have fond memories of walking the hall with Dad discussing different surgeries and What should we do about that nose?

Earlier in his training, Farzad did something very unique. During medical school, he answered a random letter from the government to help Native Americans in Montana. I loved giving back and would do it all over again. Then the year between his general residency and specialization, he packed up for Shiprock, N.M., for a full year helping Navajos by performing general surgery, lumps and bumps and concurrently getting meaningful experience.

For whats new on the horizon, Farzad said, Theres a push for innovation in less invasive procedures in the filler category. Some of the newer ones are ultrasonic therapy, microneedling, and ThermiTight. PRP (platelet-rich plasma) are injections that can repair aged skin and stimulate hair growth (in the case of hair loss) and are becoming more common.

A lot of my patients are women in their 50s, 60s and even 70s who want to look refreshed. They want the outside to match the inside.

His father, Foad, was born in Tehran, where his family was in the insurance business. He later grew up in England. After medical school at the University of Bristol in the U.K., he came in 1970 to the United States and never left. He is known as one of the most respected fathers of plastic surgery and a prominent lecturer at medical schools and symposia, and is now publishing his third edition of the reference-textbook The Art of Aesthetic Surgery while serving as Jurkiewicz Chair in Plastic Surgery and professor at Emory University School of Medicine. In total, he has authored 14 books and is currently editor-inchief of Aesthetic Surgery Journal.

Among his current contributions to scientific advances is the reduction of the length of post-surgical scarring using endoscopy.

Dr. Foad Nahai is a prolific author and Emory University medical school professor.

Foads practice now is primarily elective surgery.

His earlier career included reattaching limbs for replantation instead of transplantation. He noted, Forty years ago the rejection medications were not reliable like they are today.

Starting from a baseline, one might ask, Do I need a facelift?

Foads response: Its not a matter of age. One 50-year-old might look 65, another 50-year-old may appear to be 40. Part of this is genetics. The other part is a healthy lifestyle, not smoking, limited exposure to the sun. Those with a healthy lifestyle tend to age more slowly. It might be surprising to note that patients as young as 40 come to Dr. Nahai for this determination. Injectables (fillers, Botox, etc.) are safe and appropriate for those not yet candidates for surgery. But in the long run, surgery will produce better results and be more cost-effective.

When asked what gives him the most pride, he touts his 50-year marriage and raising skilled and caring children. Professionally, I have trained over 100 surgeons who are both ethical and competent. So I would say training others to do well is the best reward.

Sentimentally I was always secretly hoping that Farzad would choose to follow me in a medical career, but I did not push him. I am lucky; it just came naturally to him.

Read more:
Father-Son Team Creates Beauty and Healing - Atlanta Jewish Times

Global Joint Pain Injections Market Key Drivers and Opportunities Till 2028 – True Version

According to the report, the Joint Pain Injections Market: Industry Perspective, Comprehensive Analysis, and Forecast, 2019-2028 share of global Joint Pain Injections industry is dominate by companies like Vendors Covered, Vendor Classification, Market Positioning Of Vendors. Some of Major Eminent Key Players areAllergan Plc., Pfizer Inc, Sanofi, Anika Therapeutics Inc, Ferring B.V., Bioventus LLC, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Seikagaku Corporation, Chugai Pharmaceutical Co Ltd

Furthermore, the report offers an extensive standpoint of current patterns and new item dispatch in the worldwide market. Highlighting worldwide and provincial information and overdriving key players profiles, this report serves a definitive manual for investigating openings in the Joint Pain Injections business all-inclusive. The creator of the report has utilized basic language and uncomplicated factual figures that contained intensive data and complete data on the worldwide market. The report gives market players helpful data and proposes result-arranged strategies to increase an aggressive edge in the Joint Pain Injections market.

For Better Understanding, Download Free Sample PDF Brochure of Joint Pain Injections Market Research Report @https://marketresearch.biz/report/joint-pain-injections-market/request-sample

The report offers the Joint Pain Injections business development rate, size, and figures at the worldwide level likewise concerning the geographic territories. The industry-changing components for the market portions are investigated in this report. The report covers the development components of the overall market dependent on end-clients. Likewise, this report talks about the key drivers affecting market development, openings, the difficulties, and the dangers looked by key producers and the market in general. It likewise breaks down key rising patterns and their effect on present and future advancement.

Segments of Joint Pain Injections Market by :

Segmentation by Injection type:

Corticosteroid InjectionsHyaluronic Acid InjectionsOthers (include, Platelet-rich plasma (PRP), Placental tissue matrix (PTM), etc.)Segmentation by joint type:

Knee & AnkleHip JointShoulder & ElbowFacet Joints of the SpineOthers (include, Ball and socket, etc.)Segmentation by end-user:

Hospital PharmaciesRetail PharmaciesOnline Pharmacies

The study objectives of this report are:

Analyzing the outlook of the market with recent trends and SWOT analysis.

Joint Pain Injections Market dynamics scenario, along with growth opportunities of the market in the years to come.

Joint Pain Injections market segmentation analysis including quantitative and qualitative research incorporating the impact of economic and non-economic aspects.

Regional and country-level Joint Pain Injections analysis integrating the demand and supply forces that are influencing the growth.

Joint Pain Injections market value (USD Million) and volume (Units Million) data for each segment and sub-segment.

Competitive landscape affecting major players market share, as well as new projects and approaches that players have embraced over the past five years.

Comprehensive company profiles covering important economic data, product offerings, latest trends, SWOT analysis and strategies used by significant players in the market.

Any Questions? Fill Free To Enquire Here. Well Put You On The Right Path:https://marketresearch.biz/report/joint-pain-injections-market/#inquiry

The Joint Pain Injections Market report answers the questions below:

Who will be the target customers for Joint Pain Injections Market for the forecast period, 2019 to 2028?

Where are most buyers located?

What are the latest trends in the Joint Pain Injections Market? How will they impact the future of the industry during the estimated period?

Is the Joint Pain Injections Market share growing fast or declining?

Is the market large enough for the major vendors to expand their business and increase the customer base?

How many potential customers are there in a particular region?

Share Your Questions Here For More Details On this Report or Customizations As Per Your Need:https://marketresearch.biz/report/joint-pain-injections-market/#request-for-customization

Contact Us:

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue, Suite 300 New York City, NY 10170,

United States

Tel:+ 1-347-826-1876

Website:https://marketresearch.biz/

Follow this link:
Global Joint Pain Injections Market Key Drivers and Opportunities Till 2028 - True Version

Global Joint Pain Injections Market Growth Rate, Production Volume and Future Opportunities From 2019-2028 – Trade Examiner

A Recent Research By MarketResearch.Biz OnJoint Pain Injections MarketProvides A Professional, In-depth, Comprehensive, and Well-designed Insights that can help you to make better business decisions

The global Joint Pain Injections Market is studied and analyzed with the help of a complete primary and secondary market research. The report provides broad industry data on the Joint Pain Injections market, such as size, forecasted growth, profitability, key players, market share and market trends will give you a high-level overview of Joint Pain Injections market opportunities. This report studies the global market size of Joint Pain Injections, especially focuses on the key regions like North America, Europe and Asia-Pacific, South America, Middle East, and Africa

The market size section gives the Joint Pain Injections market revenues, covering historic growth of the market as well as forecasting the future. Moreover, the report covers a host of company profiles, who are making a mark in the industry or have the potential to do so. The profiling of the players includes their market size, key product launches, information regarding the strategies they employ, and others.

For Better UnderstandingThe Complete Report Through TOC, Figures, and Tables Get Free Sample Copy (Download PDF) @https://marketresearch.biz/report/joint-pain-injections-market/request-sample

List of key players profiled in the Joint Pain Injectionsmarket research report: which is very important for the manufacturers.

Allergan Plc., Pfizer Inc, Sanofi, Anika Therapeutics Inc, Ferring B.V., Bioventus LLC, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Seikagaku Corporation, Chugai Pharmaceutical Co Ltd

The Joint Pain Injections Market report also covers segment analysis, including injection type, joint type, end-user, and region etc. cover different segment market size, both volume and value.

Segmentation by Injection type:

Corticosteroid InjectionsHyaluronic Acid InjectionsOthers (include, Platelet-rich plasma (PRP), Placental tissue matrix (PTM), etc.)Segmentation by joint type:

Knee & AnkleHip JointShoulder & ElbowFacet Joints of the SpineOthers (include, Ball and socket, etc.)Segmentation by end-user:

Hospital PharmaciesRetail PharmaciesOnline Pharmacies

Key market insights thoroughly study in this comprehensive report:

1. The analysis of Joint Pain Injections market provides market size and growth rate for the forecast period 2019-2028.

2. It offers comprehensive insights into the latest trends, trend forecast, and growth factors about the Joint Pain Injections market.

3. The report provides the latest analysis of market share, investment opportunities, growth drivers, and challenges.

4. It offers a complete overview of market segments and the regional outlook of Joint Pain Injections market.

5. The report offers a detailed overview of the competitive analysis, vendor landscape, and key market strategies to gain a competitive advantage.

Inquire/Speak To Expert for Further Detailed Information About Joint Pain Injections Report:https://marketresearch.biz/report/joint-pain-injections-market/#inquiry

Worldwide research for Joint Pain Injections Industry Report examines the Below Topics:

01: Joint Pain Injections Market Overview.

02: Global Joint Pain Injections Industry outlook, revenue (USD$) and Market Size by Key application.

03: Joint Pain Injections Market distribution, Revenue (USD$) by country and region wise there Segments.

04: Global Joint Pain Injections industry market research Study.

05: Joint Pain Injections manufacturing Cost Study.

06: Joint Pain Injections value Chain and Revenue Study.

07: Joint Pain Injections Marketing research, conclusion, Study on buying and sales process.

08: Joint Pain Injections report regulatory system and installation.

09: Overall perspective for Joint Pain Injections report.

Browse CompleteTOC ofJoint Pain Injections Market@https://marketresearch.biz/report/joint-pain-injections-market/#toc

Get in touch with Us:

Mr. Benni Johnson ([emailprotected])

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Website:https://marketresearch.biz

View post:
Global Joint Pain Injections Market Growth Rate, Production Volume and Future Opportunities From 2019-2028 - Trade Examiner

Global Joint Pain Injections Market 2019 || What it got next? Find out with the latest research available at ‘MarketResearch.Biz’ – True Version

MarketResearch. Biz research report helps market players to improve their business plans and ensure long-term success. One of the most recent reports weve added to our collection is Joint Pain InjectionsMarket Report 2019

Thereport onJoint Pain Injections Marketoffers detailed value chain assessment, a comprehensive study on market dynamics including drivers, restraints and opportunities, recent trends, and industry performance analysis. Furthermore, it digs deep into critical aspects of key subjects such as market competition, regional growth, and market segmentation so that readers could gain a sound understanding of the global Joint Pain Injections market.

The report represents the statistical data in the form of tables, charts, and info-graphics to assess the market, its growth and development, and market trends of the Global Joint Pain Injections Market during the projected period.

We can provide Free Sample Pages For a Better Understanding of this Report.Download PDFof This Report @https://marketresearch.biz/report/joint-pain-injections-market/request-sample

Furthermore, the report provides insightful and comprehensive information in consideration of the different industry pioneers, including their revenue details, technological advancements, innovations, key developments, SWOT analysis, mergers & applications, future strategies, and market footprint. On the basis of segmentation, the market has been classified into injection type, joint type, end-user, and region, industry vertical, and geography.

Important Features that are under offering & key highlights of the report:

1) Who are the Leading Key Company in Joint Pain Injections market space and what are their Key Business plans and Strategies?

Following are a list of players that are currently profiled in the report Allergan Plc., Pfizer Inc, Sanofi, Anika Therapeutics Inc, Ferring B.V., Bioventus LLC, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Seikagaku Corporation, Chugai Pharmaceutical Co Ltd

2) What will the Joint Pain Injections market size be in 2028 and what will the growth rate be?

In 2019, the Joint Pain Injections market size was xx million USD and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2019-2028.

3) Joint Pain Injections Market Segmentation :

Segmentation by Injection type:

Corticosteroid InjectionsHyaluronic Acid InjectionsOthers (include, Platelet-rich plasma (PRP), Placental tissue matrix (PTM), etc.)Segmentation by joint type:

Knee & AnkleHip JointShoulder & ElbowFacet Joints of the SpineOthers (include, Ball and socket, etc.)Segmentation by end-user:

Hospital PharmaciesRetail PharmaciesOnline Pharmacies

4) What are the key trends in the Joint Pain Injections market?

5) How much revenue the Joint Pain Injections Market is likely to garner over the forecast period between 2019-2028?

Inquire/Speak To Expert for Further Detailed Information About Joint Pain Injections Report:https://marketresearch.biz/report/joint-pain-injections-market/#inquiry

Table of Contents:

Chapter One: Global Joint Pain Injections Market Overview

1.1 Joint Pain Injections Preface

Chapter Two: Global Joint Pain Injections Market Analysis

2.1 Joint Pain Injections Report Description

2.1.1 Joint Pain Injections Market Definition and Scope

2.2 Joint Pain Injections Executive Summary

2.2.1 Joint Pain Injections Market Snapshot, [Segment 1]

2.2.2 Joint Pain Injections Market Snapshot, [Segment 2]

2.2.3 Joint Pain Injections Market Snapshot, [Segment 3]

2.2.4 Joint Pain Injections Market Snapshot, [Region Segment]

2.3 Joint Pain Injections Market Opportunity Analysis

Chapter Three: Global Joint Pain Injections Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Trends

Chapter Four: Global Joint Pain Injections Market Segment Analysis, by [Segment 1]

4.1 Joint Pain Injections Overview

4.2 Joint Pain Injections Segment Trends

4.3 Joint Pain Injections Market Share and Forecast, and Y-o-Y Growth

Chapter Five: Global Joint Pain Injections Market Segment Analysis, by [Segment 2]

5.1 Joint Pain Injections Overview

5.2 Joint Pain Injections Segment Trends

5.3 Joint Pain Injections Market Share and Forecast, and Y-o-Y Growth

Chapter Six: Global Joint Pain Injections Market Segment Analysis, by [Segment 3]

6.1 Joint Pain Injections Overview

6.2 Joint Pain Injections Segment Trends

6.3 Joint Pain Injections Market Share and Forecast, and Y-o-Y Growth

Chapter Seven: Global Joint Pain Injections Market Segment Analysis, by [Region Segment]

7.1 Joint Pain Injections Overview

7.2 Joint Pain Injections Regional Trends

7.3 Joint Pain Injections Market Share and Forecast, and Y-o-Y Growth

Chapter Eight: Global Joint Pain Injections Market Company Profiles

8.1 Companies

8.1.1 Company Overview

8.1.2 Product Portfolio

8.1.3 Financial Overview

8.1.4 Key Developments

8.1.5 SWOT Analysis

Chapter Nine: Global Joint Pain Injections Market

9.1 Research Methodology

9.2 About Us

Read Out CompleteTOC ofJoint Pain Injections Market@https://marketresearch.biz/report/joint-pain-injections-market/#toc

Get in touch with Us:

Mr. Benni Johnson (inquiry@marketresearch.biz)

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Website:https://marketresearch.biz

See the original post here:
Global Joint Pain Injections Market 2019 || What it got next? Find out with the latest research available at 'MarketResearch.Biz' - True Version

Dee Ford on Monday night showdown: The blood is in the water with these games – AL.com

Defensive end Dee Ford has become a fixture on the San Francisco 49ers injury report. Every week, hes listed. But every game, hes played.

As Ford deals with knee tendinitis and irritation of the quadriceps muscle, the 49ers have picked his spots on the field. By using him as a situational pass-rusher, San Francisco has been able to get 5.5 sacks and two forced fumbles from Ford while using the former Auburn standout on 39 percent of the 49ers defense snaps.

Youre going to have nicks and bruises, Ford said during an appearance on KNBR-FM in San Francisco. Well, its not bruised; I wish it was. Ive been in situations where Ive had to handle worser things, so my maintenance, you have to keep it strong. Weve got a great strength staff, a great trainer, so were on a great plan each week, so I got to put in a little extra work, but Im the man for the job and Ill be ready to go. If I can play, Im going to play.

Ford recorded 13 sacks and led the NFL with seven forced fumbles for the Kansas City Chiefs in 2018.

The 49ers obtained Ford in March, sending a second-round selection in the 2020 NFL Draft to Kansas City after the Chiefs had placed their franchise tag on the pass-rusher to keep him off the free-agent market.

San Francisco signed Ford to a five-year, $85.5 million contract and addressed his left-knee condition by having Ford get platelet-rich plasma injections while missing about four weeks of the training camp/preseason period.

I love my teammates, and thats a real thing, Ford said of his move to San Francisco. I know a lot of teammates say that, but weve been building chemistry since OTAs, so where were at right now as team is special, special, especially upfront.

San Francisco is the NFL's only undefeated team after winning four games last season. The 49ers defense has given up the fewest total yards and the fewest passing yards in the NFL in 2019.

A key component to San Francisco's defensive success has been its pass rush. The 49ers rank fourth in the NFL with 30 sacks.

All four guys have to work together, and we really put in the effort to work together, Ford said of the 49ers defensive line. "You can look around the league. Theres a lot of D-lines that its just not the same result and some play as individuals. Im not throwing shade, but we really work together. And thats a lot of credit to Kris Kocurek, our (defensive-line) coach. He really helped us glue the thing together and play together. We do not play as individuals.

"As you can see, you never know who's going to have -- that's the crazy part about these games: You don't know who's going to have the hot hand upfront. You never know. But we all play together. Nobody's trying to make the big play. Everybody wants to get sacks, of course, but nobody's coming out of what we do to try to make a play, and that's the special thing about this front."

Rookie defensive end Nick Bosa leads the 49ers with seven sacks, but 10 San Francisco players have recorded sacks in 2019.

I think theyre the top group in the whole league and just their style of play, the way theyre coaching them, Seattle Seahawks coach Pete Carroll said. I think Bosa adding to those guys has been a big addition. Dee Ford has really fit in well on third-down situations. Theyre flying and theyre about as good as you can hope to be now. Theyre really getting it done.

The 49ers will square off against the Seahawks in an NFC West rivalry game at 7:15 p.m. CST Monday at Levi's Stadium in Santa Clara, California. ESPN will televise the game.

Seattle will enter the final game of Week 10 of the NFL's 2019 season with a 7-2 record. San Francisco has an 8-0 mark after beating the Arizona Cardinals 28-25 on Oct. 31 in the first game of Week 9.

I felt it as soon as the Arizona game was over: Its Seattle week, Ford said. Its real, man. Its a real thing. The blood is in the water with these games. You never know what youre going to get, so both teams have to gear up.

Ford traces his current knee problem to a 2013 injury, when he tore the medial collateral ligament in his left knee about two weeks before his senior season at Auburn kicked off. Ford missed the first two games, but he returned to register 10.5 sacks as the Tigers won the SEC championship and reached the BCS national-championship game.

Back surgery for a herniated disk in 2011 had caused Ford to take a medical redshirt after his first two seasons at Auburn. The former St. Clair County High School star also required back surgery again that cost him 10 games during the 2017 NFL season.

Mark Inabinett is a sports reporter for Alabama Media Group. Follow him on Twitter at @AMarkG1.

More NFL coverage:

Check out Rashaan Evans 53-yard scoop-and-score for his first NFL touchdown

Sunday will feel a little weird for Steelers Mark Barron

Green Bay feeling like Auburn to Montravius Adams

Josh Jacobs TD run lifts Raiders to Thursday night win

Fred Biletnikoff: Ken Stabler should have been MVP of Super Bowl XI

Jermaine Whitehead: That was totally out of character for me

Carolina Panthers put Cam Newton on injured reserve

Joe Namath, Bo Jackson included among NFLs greatest game changers

Continued here:
Dee Ford on Monday night showdown: The blood is in the water with these games - AL.com

Burning in knee: 7 causes and how to treat them – Medical News Today

Knee joints are under a lot of physical stress each day. It is very common to experience pain in one or both knees due to normal wear and tear, physical activity, or injury. Often, if a person has a knee injury or strain, the pain can feel as though it is burning.

Burning knee pain can occur in many places in the knee. For many people, the fronts and backs of the knees are the most common spots to feel a burning sensation. Sometimes, however, the sides of the knees can also feel as though they are burning.

A burning sensation in any part of the knee typically indicates that there is a larger problem that may require investigation and treatment.

This article explores some common causes of burning pain in the knee, the typical treatments for them, and when to see a doctor.

The location of the burning knee pain can often give some clues as to what is causing it. The sections below list some causes of location-specific knee pain.

Burning pain in the front of the knee is often due to injuries such as:

If a person has burning pain on the side of the knee, it could be due to iliotibial band syndrome or pes anserine bursitis.

Burning pain behind the knee may be due to:

The following sections detail some potential causes of burning knee pain and how to treat them.

Knee cartilage, or meniscus, helps cushion the joint during physical activities such as walking, running, and jumping. If a person sustains a blunt force injury to this area or twists it forcefully, it can tear the knee cartilage. This is painful and can feel like burning.

There are various treatment options for a knee cartilage tear. Often, the first steps in treatment involve taking pain relief drugs such as ibuprofen and trying muscle strengthening workouts.

If the knee cartilage does not improve, a doctor or healthcare team may recommend steroid injections in the knee or surgical options such as:

Knee ligament tears often occur due to blunt force trauma to the outside of the knee. People who play hockey, football, or other contact sports are at greater risk of tearing or pulling their knee ligaments.

Health professionals often classify ligament tears by how severe they are. A partial tear may require less treatment than a severe tear. Some treatment options for partial tears include:

If the tear is very severe or does not improve, a doctor may recommend surgical options.

Runner's knee, also known as chondromalacia, occurs as a result of overuse of the knee joint. It is particularly common among runners and other people who put consistent pressure and stress on their knees.

Chondromalacia occurs when the knee cartilage deteriorates, providing less cushioning to the joint.

The first steps in treatment often involve therapies to help reduce pain and swelling and allow the knee to heal. Some treatments include:

If the knee does not improve, a healthcare team may recommend arthroscopic surgery. This involves smoothing the cartilage to allow it to heal better.

Osteoarthritis is the most common form of arthritis in the United States. In fact, around 30.8 million people now live with the condition.

Osteoarthritis can affect nearly any joint, but it is most common in the hands, hips, spine, and knees.

Osteoarthritis is characterized by the wearing down of the protective cartilage in the joints. It is not possible to reverse osteoarthritis, so it may eventually require a joint replacement.

Some common treatments for osteoarthritis include:

Patellar tendinitis is an overuse injury of the tendon that connects the kneecap to the shin. It can cause burning and pain in the front of the knee.

There are several potential treatment steps a person can take to treat patellar tendinitis, including:

If these therapies do not work, a doctor may recommend more invasive therapies, such as a platelet-rich plasma injection or oscillating needle procedure.

Iliotibial band syndrome (ITBS) often affects runners. It occurs when the connective tissue along the length of the thigh rubs against the outside of the knee during running and other physical activities.

ITBS can feel like burning when the band rubs against the side of the knee.

There is no formal treatment for ITBS. However, people with this condition often take some of the following steps:

PFPS occurs in the front of the knee. It often starts as mild pain and gradually builds up. It can occur in one or both knees. It is usually worse during physical activities.

Some general treatment options for PFPS include:

In more severe cases, a doctor may recommend arthroscopic surgery, which involves removing and smoothing damaged cartilage.

In some cases, a person may receive treatment shortly after sustaining a knee injury. In others, a person may first try to deal with the pain they experience, only seeing their doctor when it becomes severe.

For overuse injuries, the best solution is often to rest, apply an ice pack, and focus on muscle building activities that do not put strain on the knees. However, if the pain continues to build despite resting, a person should talk to their doctor about their symptoms.

They may be able to recommend additional therapies, such as physical or occupational therapy. In severe cases, they may even recommend surgical options.

Several things can give rise to burning knee pain. Some injuries are acute and can start causing pain immediately, while others are overuse-related and will build up gradually.

In many cases, taking OTC pain relievers, applying an ice pack, and resting are enough to help prevent further injury and pain. If the pain does not go away or gets worse, however, a doctor may suggest surgery or more invasive treatment options.

Read the original:
Burning in knee: 7 causes and how to treat them - Medical News Today

Joint Pain Injections Market to Expand at a Positive CAGR, Rising Support from Government in Research Activities to Boost the Market – News Reel Hub

Joint Pain Injections Market summarizes details y key players are Anika, Therapeutics, Inc., Teva Pharmaceuticals Industries Ltd.Flexion Therapeutics Inc., Pfizer Inc., Reddys Laboratories Ltd., Zimmer Biomet, Bioventus, SEIKAGAKU CORPORATION and more

The information is shared by Fortune Business Insights, in a report, titled Joint Pain Injections Market Size, Share and Global Trend By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Others (Placental Tissue Matrix Injections, etc), By Joint Type (Knee and Ankle, Hip, Shoulder and Elbow, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026.

CDC reports that every year approximately 15 million people in the U.S. face severe joint pain because of arthritis. The rising prevalence of arthritis can increase the demand for treatments, which in turn, will propel the growth of the global joint pain injections market.

Browse Complete Report Details at

https://www.fortunebusinessinsights.com/industry-reports/joint-pain-injections-market-100871

Some of the other players functioning in the global market are

One of the most common types of arthritis is osteoarthritis which primarily affects hands and feet. Some of the major causes associated with osteoarthritis are the rising prevalence of obesity, increasing aging population, zero physical activity, and mineral bone density loss. Injections such as hyaluronic acid and corticosteroid are extensively used to reduce pain and inflammation in affected areas.

Joint pains are more prevalent in the elderly population. As per research studies, injections such as platelet-rich plasma and placental tissue matrix have proved to be effective in the reduction of pain and inflammation. Furthermore, these infections will substantially reduce the risk of infection on the affected joint in the aged population. Driven by such factors, the joint pain injections market growth is likely to increase in the forthcoming years.

Get Sample PDF Brochure at

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/joint-pain-injections-market-100871

Surging Research Investments to Give Significant Boost to the Market in North America

According to Arthritis Foundation, around 54 million people in the people suffer from arthritis and it is estimated that over 78 million people will be affected by this disease by 2040. This shows that the demand for joint pain medicine is likely to increase in the U.S., which drives the market in North America. As per the report, North America is anticipated to maintain its dominance in the global joint pain infections market through the forecast years.

The growth is primarily attributable to the increasing prevalence of joint disorders. People in this region are increasingly becoming aware of joint pain infections treatment. Not only this, leading players are making huge investments in research activities, which will eventually drive the market in North America.

Several treatments such as knee arthritis viscosis supplementation received FDA approval, which contributes to the growth of the market in this region. Following North America, Europe is also expected to grow at a considerable rate in the forecast period.

The market in Asia Pacific is expected to witness considerable growth owing to the rising prevalence of joint disorders and patient pool. Several government organizations are conducting awareness programs on different types of arthritis treatments available in the region. This will enhance the quality of life for such patients and augment demand for joint pain injections. Influenced by these factors, the joint pain infections market size is estimated to grow over the projected horizon.

Segmentation for Joint Pain Injections Market

By Product

By Joint Type

By Distribution Channel

By Geography

Speak To Analyst at

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/joint-pain-injections-market-100871

SYNOJOYNTReceives FDA Approval to Teva Pharmaceuticals for Treating Osteoarthritis Patients

Joint pain injections are available for different joints which include hip, knee and ankle, shoulder and elbow. Of these, knee and ankle joints hold the largest share in the global market. This will surge the joint pain injections market size in the forthcoming years. These injections effectively reduce inflammation and pain in knees, thus increasing their demand.

The demand for cost-effective treatments is increasing and the rising prevalence of osteoarthritis are driving the joint pain injections market, stated a lead analyst at Fortune Business Insights. These, coupled with rising technological advancements in healthcare, are likely to uplift the market growth. Several companies are introducing new products to strengthen their market position.

SYNOJOYNT, a joint pain injection receives FDA approval on marketing this product. The injection was introduced by TEVA Pharmaceuticals in May 2018 for patients suffering from osteoarthritis. Zimmer Biomet develops a new joint pain injection containing hydraulic acid called Gel-One Hyaluronate. The injection received FDA approval in February 2017 and is used to treat patients with knee osteoarthritis.

STRONG INDUSTRY FOCUS:

View Related Report at

Europe Compression Bandages Market to Witness a Healthy CAGR of 5.2%; Advent of Efficient Pressure Bandages to Provide Impetus

Why the Medical Lasers Market is set to explode? Top Companies: El.En. S.p.A., Lumenis, Fotona, Ellex Medical Lasers Ltd., BIOLASE, Inc., Sisram Medical Ltd. And more

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune 411045, Maharashtra, India.

Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: [emailprotected]

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Joint Pain Injections Market to Expand at a Positive CAGR, Rising Support from Government in Research Activities to Boost the Market

More here:
Joint Pain Injections Market to Expand at a Positive CAGR, Rising Support from Government in Research Activities to Boost the Market - News Reel Hub

Platelet Rich Plasma Injections Cost Outlook and Opportunities in Grooming Regions – Young Gazzete

With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global platelet rich plasma market as well as the factors responsible for such a growth. Our highly dedicated professionals have inputted critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research.

We leverage space-age industrial and digitalization tools to provide avant-garde actionable insights to our clients regarding the platelet rich plasma injections cost. For enhancing readers experience, the report starts with a basic overview about the platelet rich plasma market and its classification. Further, we have considered 2012 as the base year, 2022 as the estimated year, 2017 2022 as the stipulated timeframe.

Competitive Assessment

The platelet rich plasma market report includes global as well as emerging players:

The insights for each vendor consists of:

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=170

Regional Analysis

Important regions covered in the platelet rich plasma market report include:

The platelet rich plasma market report also provides data regarding the key countries in the defined regions.

Segmentation Analysis

By Product:

By end use:

What insights does the platelet rich plasma market report provide to the readers?

For a broader and insightful view of the competition landscape, request for the Sample report: https://www.factmr.com/connectus/sample?flag=S&rep_id=170

Questionnaire answered in the platelet rich plasma market report include:

And many more

Go here to read the rest:
Platelet Rich Plasma Injections Cost Outlook and Opportunities in Grooming Regions - Young Gazzete